• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Panbela Announces Publication of Clinical Data Titled: Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan

    GLOBENEWSWIRE

    Ipsen Announces Results from Phase III RESILIENT Trial Evaluating Onivyde

    BUSINESSWIRE

    Teva`s troubled plant seen to create injectable drug shortages

    FIERCEPHARMA

    PharmaMar, Jazz Announce Initiation of Confirmatory Phase 3 Trial of Zepzelca

    PRNEWSWIRE

    EMD Serono to Highlights From Oncology Portfolio at WCLC & ESMO 2021

    BUSINESSWIRE

    Enforcement Report - Week of July 14, 2021

    FDA

    Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL

    FDA

    Aileron Announces Positive Interim Results from Ph1b/2 Trial of ALRN-6924

    GLOBENEWSWIRE

    AbbVie shuts Rova-T development in first-line advanced small-cell lung cancer

    PHARMAFILE

    Mylan Lab’s Generic Topotecan Hydrochloride Receives Approval In US

    FDA

    Accord’s Generic Topotecan Hydrochloride Receives Approval In US

    FDA

    US expands scope of Avastin in ovarian cancer

    PHARMATIMES

    Ingenus`s Generic Topotecan HCL Receives Approval In US

    FDA

    PharmaMar pits small cell lung cancer hopeful against competition in PhIII trial

    FIERCE BIOTECH

    NICE ovarian cancer guideline recommends two drugs, but rejects three

    PHARMATIMES

    Why Evidence From A Randomized Clinical Trial For Ovarian Cancer Treatment Has Limited Value

    FORBES

    Cisplatin Injection 1 mg/mL, Gemcitabine for Injection, USP 1g and 2 g per vial, and Topotecan HCl for Injection 4 mg per vial - Recall of Lots Which May Contain Foreign Particulate Matter

    HEALTHY CANADIANS

    GSK Deal`s Done. Now, Novartis Has To Deliver On Cancer-Growth Pledge

    FIERCE PHARMA

    Roche’s Avastin Plus Chemotherapy Receives Positive Recommendation From CHMP For EU Approval In Advanced Cervical Cancer

    ROCHE

    PharmaMar Will Start a Phase III study of PM1183 in Combination With Doxorubicin in Relapsed SCLC

    PHARMAMAR

    NICE Reviews Five Ovarian Cancer Drugs

    PHARMA TIMES

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.